Abstract:DNA targeting Class 2 CRISPR-Cas effector nucleases, including the well-studied Cas9 proteins, evolved protospacer-adjacent motif (PAM) and guide RNA interactions that sequentially license their binding and cleavage activities at protospacer target sites. Both interactions are nucleic acid sequence specific but function constitutively; thus, they provide intrinsic spatial control over DNA targeting activities but naturally lack temporal control. Here we show that engineered Cas9 fusion proteins which bind to nascent RNAs near a protospacer can facilitate spatiotemporal coupling between transcription and DNA targeting at that protospacer: anscription- ssociated as9 argeting (TraCT). Engineered TraCT is enabled in eukaryotic yeast or human cells when suboptimal PAM interactions limit basal activity and when one or more nascent RNA substrates are still tethered to the actively transcribed target DNA in . Using yeast, we further show that this phenomenon can be applied for selective editing at one of two identical targets in distinct gene loci, or, in diploid allelic loci that are differentially transcribed. Our work demonstrates that temporal control over Cas9’s targeting activity at specific DNA sites may be engineered without modifying Cas9’s core domains and guide RNA components or their expression levels. More broadly, it establishes co-transcriptional RNA binding as a -acting mechanism that can conditionally stimulate CRISPR-Cas DNA targeting in eukaryotic cells.

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

Expanding The Crispr Imaging Toolset With Staphylococcus Aureus Cas9 For Simultaneous Imaging Of Multiple Genomic Loci

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Genome editing with natural and engineered CjCas9 orthologs

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators

Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity

An enhanced CRISPR repressor for targeted mammalian gene regulation

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations

Applications of Cas9 as an RNA-programmed RNA-binding protein

Genome-wide Binding of the CRISPR Endonuclease Cas9 in Mammalian Cells

Genome engineering using the CRISPR-Cas9 system

Screening DNA Aptamers That Control the DNA Cleavage, Homology-Directed Repair, and Transcriptional Regulation of the CRISPR-(d)Cas9 System.

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos